Current thinking on chronic renal allograft rejection: Issues, concerns, and recommendations from a 1997 roundtable discussion

American Journal of Kidney Diseases

Volumn 33, Issue 1, 1999, Pages 150-160

  Monaco, A P ^a   Burke J F , Jr ^a   Ferguson, R M ^a   Halloran, P F ^a   Kahan, B D ^a   Light, J A ^a   Matas, A J ^a   Solez, K ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Chronic rejection; Compliance; Cyclosporine; Immunosuppression; Nephron mass; Renal biopsy; Renal transplant; Serum creatinine

Indexed keywords

AZATHIOPRINE; CALCINEURIN; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; UNCLASSIFIED DRUG;

ARTICLE; CREATININE BLOOD LEVEL; DETERIORATION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; PATIENT COMPLIANCE; RISK FACTOR;

EID: 0032952860     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70273-8     Document Type: Article

References (47)

1. JM Cecka The UNOS Scientific Renal Transplant Registry JM Cecka PI Terasaki Clinical Transplants 1996 1997 UCLA Tissue Typing Laboratory Los Angeles, CA 1 14
2. HM Lee Chronic rejection: Pathogenesis and treatment Transplant Proc 28 1996 1146 1147
3. AJ Matas Chronic rejection: Definition and correlates Clin Transplant 8 1994 162 167
4. TH Hostetter Chronic transplant rejection Kidney Int 46 1994 266 279
5. NL Tilney WD Whitley JR Diamond JW Kupiec-Weglinski DH Adams Chronic rejection: An undefined conundrum Transplantation 52 1991 389 398
6. ST Shaikewitz L Chan Chronic renal transplant rejection Am J Kidney Dis 23 1994 884 893
7. FM Modena TH Hostetter AK Salahudeen JS Najarian AJ Matas ME Rosenberg Progression of kidney disease in chronic renal transplant rejection Transplantation 52 1991 239 244
8. K Solez RA Axelsen H Benediktsson JF Burdick AH Cohen RB Colvin BP Croker D Droz MS Dunnill PF Halloran P Häyry JC Jennette PA Keown N Marcussen MJ Mihatsch K Morozumi BD Myers CC Nast S Olsen LC Racusen EL Ramos S Rosen DH Sachs DR Salomon F Sanfilippo R Verani E von Willebrand Y Yamaguchi International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology Kidney Int 44 1993 411 422
9. BL Kasiske RSN Kalil HS Lee KV Rao Histopathologic findings associated with a chronic, progressive decline in renal allograft function Kidney Int 40 1991 514 524
10. K Solez H Benediktsson T Cavallo B Croker AJ Demetris C Drachenberg S Emancipator PN Furness LW Gaber IW Gibson J Gough R Gupta P Halloran P Häyry M Kashgarian N Marcussen ZA Massy MJ Mihatsch K Morozumi I Noronha S Olsen J Papadimitriou LC Paul M Picken LC Racusen EL Ramos P Randhawa DC Rayner D Rush F Sanfilippo E Taskinen K Trpkov L Truong Y Yamaguchi S Yilmaz Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology Transplant Proc 28 1996 441 444
11. K Morozumi T Oikawa M Fukuda K Sugito O Takeuchi A Oda T Fujinami A Takeda K Uchida Diagnosis of chronic rejection using peritubular and glomerular capillary lesions Transplant Proc 28 1996 508 511
12. EH Strøm R Epper MJ Mihatsch Ciclosporin-associated arteriolopathy: the renin producing vascular smooth muscle cells are more sensitive to ciclosporin toxicity Clin Nephrol 43 1995 226 231
13. RB Colvin AH Cohen C Saiontz S Bonsib M Buick B Burke S Carter T Cavallo M Haas A Lindblad JC Manivel CC Nast D Salomon C Weaver M Weiss Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation J Am Soc Nephrol 8 1997 1930 1941
14. H Isoniemi E Taskinen P Häyry Histological chronic allograft damage index accurately predicts chronic renal allograft rejection Transplantation 58 1994 1195 1198
15. PS Almond A Matas K Gillingham DL Dunn WD Payne P Gores R Gruessner JS Najarian Risk factors for chronic rejection in renal allograft recipients Transplantation 55 1993 752 757
16. PS Almond AJ Matas K Gillingham DL Dunn WD Payne P Gores R Gruessner JS Najarian Predictors of chronic rejection in renal transplant recipients Transplant Proc 25 1993 936
17. AJ Matas KJ Gillingham WD Payne JS Najarian The impact of an acute rejection episode on long-term renal allograft survival (t1/2) Transplantation 57 1994 857 859
18. JM Cecka YW Cho PI Terasaki Analyses of the UNOS Scientific Renal Transplant Registry at three years: Early events affecting transplant success Transplantation 53 1992 59 64
19. JE Leggat Jr AO Ojo AB Leichtman FK Port RA Wolfe MN Turenne PJ Held Long-term renal allograft survival: Prognostic implication of the timing of acute rejection episodes Transplantation 63 1997 1268 1272
20. GP Basadonna AJ Matas KJ Gillingham WD Payne DL Dunn DER Sutherland PF Gores RWG Gruessner JS Najarian Early versus late acute renal allograft rejection: Impact on chronic rejection Transplantation 55 1993 993 995
21. B Chavers M Mauer K Gillingham A Matas Histology of acute rejection impacts renal allograft survival in patients with a single rejection episode J Am Soc Nephrol 6 1995 1076
22. NL Reinsmoen AJ Matas Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity Transplantation 55 1993 1017 1023
23. DR Salomon Cyclosporine nephrotoxicity and long-term renal transplantation Transplant Rev 6 1992 10 19
24. DR Salomon An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients Transplant Proc 23 1991 2115 2118
25. BD Kahan M Welsh L Schoenberg LP Rutzky SM Katz DL Urbauer CT Van Buren Variable oral absorption of cyclosporine: A biopharmaceutical risk factor for chronic renal allograft rejection Transplantation 62 1996 599 606
26. S Savoldi R Maiorca M Maderna R Chiappini G Corbetta Low intrapatient variability of blood cyclosporine levels is correlated with excellent graft survival Transplant Proc 29 1997 288 289
27. BD Kahan J Dunn C Fitts D Van Buren D Wombolt R Pollak R Carson JW Alexander M Choc R Wong DS Hwang Reduced inter-and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals Transplantation 59 1995 505 511
28. PF Halloran Aspects of allograft rejection, IV: Evaluation of new pharmacologic agents for prevention of allograft rejection Transplant Rev 9 1995 138 146
29. PF Halloran Molecular mechanisms of new immunosuppressants Clin Transplant 10 1996 118 123
30. SL Schreiber GR Crabtree The mechanism of action of cyclosporin A and FK506 Immunol Today 13 1992 136 142
31. J Liu JD Farmer Jr WS Lane J Friedman I Weissman SL Schreiber Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes Cell 66 1991 807 815
32. TD Batiuk PF Halloran The downstream consequences of calcineurin inhibition Transplant Proc 29 1997 1239 1240
33. TD Batiuk F Pazderka PF Halloran Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients Transplantation 59 1995 1400 1404
34. TD Batiuk F Pazderka J Enns L DeCastro PF Halloran Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible J Clin Invest 96 1995 1254 1260
35. TD Batiuk J Urmson D Vincent RW Yatscoff PF Halloran Quantitating immunosuppression: Estimating the 50% inhibitory concentration for in vivo cyclosporine in mice Transplantation 61 1996 1618 1624
36. BM Brenner RA Cohen EL Milford In renal transplantation, one size may not fit all J Am Soc Nephrol 3 1992 162 169
37. F Längle T Sautner T Grünberger P Götzinger G Schuster E Pohanka R Steininger F Mühlbacher Impact of donor age on graft function in living-related kidney transplantation Transplant Proc 24 1992 2725 2727
38. DA Shoskes PF Halloran Delayed graft function in renal transplantation: etiology, management and long-term significance J Urol 155 1996 1831 1840
39. I Yokoyama K Uchida T Kobayashi Y Tominaga A Orihara H Takagi Effect of prolonged delayed graft function on long-term graft outcome in cadaveric kidney transplantation Clin Transplant 8 1994 101 106
40. TH Hostetter JL Olson HG Rennke MA Venkatachalam BM Brenner Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation Am J Physiol 241 1981 F85 F93
41. C Troppmann KJ Gillingham E Benedetti PS Almond RWG Gruessner JS Najarian AJ Matas Delayed graft function, acute rejection, and outcome after cadaver renal transplantation: A multivariate analysis Transplantation 59 1995 962 968
42. C Troppmann KJ Gillingham RWG Gruessner DL Dunn WD Payne JS Najarian AJ Matas Delayed graft function in the absence of rejection has no long-term impact: A study of cadaver kidney recipients with good graft function at 1 year after transplantation Transplantation 61 1996 1331 1337
43. FG Cosio ME Falkenhain TE Pesavento ML Henry EA Elkhammas EA Davies GL Bumgardner RM Ferguson Relationships between arterial hypertension and renal allograft survival in African-American patients Am J Kidney Dis 29 1997 419 427
44. FG Cosio RP Pelletier ME Falkenhain ML Henry EA Elkhammas EA Davies GL Bumgardner RM Ferguson Impact of acute rejection and early allograft function on renal allograft survival Transplantation 63 1997 1611 1615
45. SG Tullius NL Tilney Both alloantigen-dependent and -independent factors influence chronic allograft rejection Transplantation 59 1995 313 318
46. SG Tullius WW Hancock U Heemann H Azuma NL Tilney Reversibility of chronic renal allograft rejection: Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury Transplantation 58 1994 93 99
47. PF Halloran J Homik N Goes SL Lui J Urmson V Ramassar SM Cockfield The ″injury response”: A concept linking nonspecific injury, acute rejection, and long-term transplant outcomes Transplant Proc 29 1997 79 81